RecruitingNCT06427304

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Sponsor

Gérond'if

Enrollment

637 participants

Start Date

Jul 1, 2024

Study Type

OBSERVATIONAL

Conditions

Cardiac Amyloidosis

Summary

Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography

Eligibility

Min Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is looking for cardiac amyloidosis — a condition where abnormal proteins build up in the heart muscle — in elderly patients who have been hospitalized for heart failure. Many cases of cardiac amyloidosis go undiagnosed, and this study aims to identify them using a bone scan (scintigraphy). **You may be eligible if...** - You are 80 years old or older - You have been hospitalized for worsening heart failure in the past 12 months - An echocardiogram (heart ultrasound) showed thickening of your heart walls (septum ≥ 12 mm) - You are able to undergo a bone scintigraphy scan - You are willing to participate **You may NOT be eligible if...** - You have already been diagnosed with cardiac amyloidosis - You are currently in palliative care - You are under legal guardianship - You refuse to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(36)

Geriatric Department, Broca Hospital

Paris, IIe-de-France, France

CHU Nantes

Nantes, Loire-Atlantique, France

CHU Poitiers

Poitiers, New Aquitaine, France

CHU Rouen, Charles Nicole hospital

Rouen, Normandy, France

CHU Montpellier

Montpellier, Occitanie, France

CHU Toulouse

Toulouse, Occitanie, France

CHU Amiens Picardie

Amiens, France

CHU Angers

Angers, France

CHU Bordeaux

Bordeaux, France

Centre Hospitalier de Carcassonne

Carcassonne, France

Centre Hospitalier Intercommunal de Castres-Mazamet

Castres, France

CHU Trousseau-Tours

Chambray-lès-Tours, France

CHU Dijon

Dijon, France

CHU Grenoble Alpes

Grenoble, France

CHU Lille

Lille, France

CHU Limoges

Limoges, France

CHU Lyon

Lyon, France

CHU Marseille

Marseille, France

Clinique du Millénaire-Montpellier

Montpellier, France

CHRU Nancy

Nancy, France

CHU Nice

Nice, France

Hôpital Privé Gériatrique LES SOURCES-Nice

Nice, France

CHU Orléans

Orléans, France

CHU Rennes

Rennes, France

CHRU Tours-Bretonneau Hospital

Tours, France

Clinique Saint Joseph Trelaze

Trélazé, France

Médipôle Hôpital Mutualiste Villeurbanne

Villeurbanne, France

Ambroise Paré Hospital

Boulogne-Billancourt, Île-de-France Region, France

Corentin Celton Hospital

Issy-les-Moulineaux, Île-de-France Region, France

Charles Foix Hospital

Ivry-sur-Seine, Île-de-France Region, France

Emile Roux Hospital

Limeil-Brévannes, Île-de-France Region, France

GH Sud Ile-de-France

Melun, Île-de-France Region, France

Lariboisière Hospital

Paris, Île-de-France Region, France

Saint Joseph Hospital

Paris, Île-de-France Region, France

Europeen Georges Pompidou Hospital

Paris, Île-de-France Region, France

Bretonneau Hospital

Paris, Île-de-France Region, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06427304

Related Trials

[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy

NCT075603061 location

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

NCT073363941 location

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Conditions

Summary

Eligibility

Plain Language Summary

Locations(36)

Related Trials

[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy

A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation

Test-retest Study With [18F]FBB in Cardiac Amyloidosis

CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques